期刊
CURRENT ALZHEIMER RESEARCH
卷 9, 期 9, 页码 1030-1042出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156720512803569028
关键词
Abeta; Alzheimer's disease; differentiation; migration; neural progenitor cell; stem cell; transplantation
资金
- Sigrid Juselius Foundation
- Academy of Finland
Enhancement of neurogenesis and stem cell transplantation are potential therapies for neurodegenerative diseases. In Alzheimer's disease (AD) newborn neural cells and the transplanted cells encounter a diseased brain where the accumulation of toxic amyloid-beta (A beta) peptides disturbs normal functions and interactions of brain cells. In addition, AD-linked mutatations in newborn neurons or autologously transplanted neural progenitor cells (NPCs) are likely to affect the fate of these cells. Here we analyzed the effect of AD-linked APdE9 mutant on NPCs in culture and by isolating NPCs from APdE9 transgenic mice and transplanting them into APdE9 and wild type mouse brain. We show that the brain environment in APdE9 mutant mice reduced astrocytic differentiation but increased the survival and migration of NPCs in vivo. APdE9 mutation of NPCs increased neuronal differentiation also in vitro. Instead extracellular A beta(42) peptide decreased the survival, neuronal differentiation and migration of NPCs in vitro, whereas A beta(40) had an opposite effect. NPC transplantation induced brain neurogenesis, which was not altered in A beta burdened APdE9 brain or by APdE9 mutant in NPCs. Thus, AD-linked mutations in newborn neural cells or NPCs do not compromise the utilization of enhanced neurogenesis or autologous NPC transplantation as potential therapies. The results suggest that combining the treatments resulting in reduced A beta(42) and enhanced neurogenesis may be one therapeutic approach to be explored in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据